Author(s)

Mustapha Hemama, Salma Mrichi, Nizare El Fatemi, Moulay Rachid El Maaqili

Department of Neurosurgery, Ibn Sina University Hospital, Rabat, Morocco.

Approximately, 20% of all cancer patients will end up having brain metastases. This is especially the case of patients in which the primary tumor is lung cancer, breast and colorectal cancers, melanoma, or renal cell carcinoma. Development of brain metastases contributes substantially to overall cancer mortality in patients with advanced-stage cancer given the associated poor prognosis despite multimodal treatments and advances in systemic therapies. The objective of this retrospective single center study is to describe the experience of the Department of Neurosurgery of the Ibn Sina University Hospital in Rabat in the management of patients with brain metastases, highlighting the therapeutic choices as well as the various challenges encountered during treatment.

Brain, Metastases, Therapeutic Management

Hemama, M. , Mrichi, S. , Fatemi, N. and Maaqili, M. (2022) Management of Cerebral Metastases—About 25 Cases. Open Journal of Modern Neurosurgery, 12, 160-166. doi: 10.4236/ojmn.2022.123017.